$0.1870
-0.0133-6.64%
Last update: Nov 10, 7:29 PM
Context Therapeutics Inc
CNTXNASDAQ
The average analyst price target for Context Therapeutics is $5.69, 2775.2% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $4 to $9. The latest change came on Jun 16, 2026, when Maxim Group lowered its price target on Context Therapeutics from $8 to $4 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
